Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| IQV - IQVIA | 3.68% | Add +8.5% | 3,171,083 | $236.97 | $751M | +248,051 | +$133M |
| EXEL - Exelixis | 3.23% | Reduce −6.2% | 25,410,500 | $25.95 | $659M | −1,692,000 | +$50M |
| UNH - Unitedhealth Group | 3.14% | Reduce −32.2% | 1,097,900 | $584.68 | $642M | −520,300 | −$182M |
| MSFT - Microsoft | 3.09% | Add +21.9% | 1,466,747 | $430.30 | $631M | +263,969 | +$94M |
| AON - AON PLC · CL A | 2.89% | Reduce −9.0% | 1,706,000 | $345.99 | $590M | −169,200 | +$40M |
| NTRA - Natera | 2.83% | Add +2.2% | 4,557,309 | $126.95 | $579M | +96,752 | +$96M |
| TRU - Transunion | 2.81% | Reduce −9.3% | 5,475,319 | $104.70 | $573M | −559,800 | +$126M |
| DIS - Disney Walt | 2.74% | Add +62.7% | 5,829,568 | $96.19 | $561M | +2,247,400 | +$205M |
| CRM - Salesforce | 2.74% | Reduce −30.6% | 2,044,938 | $273.71 | $560M | −901,900 | −$198M |
| RVMD - Revolution Medicines | 2.51% | Add +16.0% | 11,317,692 | $45.35 | $513M | +1,560,000 | +$135M |
| NYT - New York Times · CL A | 2.38% | Reduce −11.8% | 8,744,846 | $55.67 | $487M | −1,174,994 | −$21M |
| BSX - Boston Scientific | 2.22% | Add +32.0% | 5,425,657 | $83.80 | $455M | +1,316,500 | +$138M |
| ARMK - Aramark | 2.21% | Reduce −31.3% | 11,636,937 | $38.73 | $451M | −5,292,300 | −$125M |
| TMO - Thermo Fisher Scientific | 2.15% | Reduce −4.0% | 709,456 | $618.57 | $439M | −29,700 | +$30M |
| GOOG - Alphabet · CL C | 1.97% | Add +34.2% | 2,410,540 | $167.19 | $403M | +614,000 | +$73M |
| WAB - Wabtec | 1.97% | Add +1.0% | 2,211,398 | $181.77 | $402M | +21,900 | +$56M |
| INTU - Intuit | 1.92% | Add +0.3% | 630,697 | $621.00 | $392M | +1,600 | −$22M |
| CBRE - CBRE Group · CL A | 1.81% | Reduce −21.3% | 2,970,400 | $124.48 | $370M | −802,600 | +$34M |
| ADI - Analog Devices | 1.66% | Add +14.6% | 1,472,100 | $230.17 | $339M | +187,300 | +$46M |
| LNTH - Lantheus | 1.59% | Add +29.7% | 2,955,227 | $109.75 | $324M | +676,000 | +$141M |
| Sarepta Therapeutics | 1.58% | Add +12.4% | 2,580,000 | $124.89 | $322M | +285,000 | −$40M |
| ABNB - Airbnb · CL A | 1.47% | Add +39.4% | 2,371,200 | $126.81 | $301M | +670,200 | +$43M |
| NDAQ - Nasdaq | 1.34% | Reduce −49.9% | 3,762,271 | $73.01 | $275M | −3,744,448 | −$178M |
| NOW - Servicenow | 1.29% | Reduce −35.0% | 295,050 | $894.39 | $264M | −159,000 | −$93M |
| PTGX - Protagonist Therapeutics | 1.29% | Add +0.3% | 5,861,006 | $45.00 | $264M | +20,233 | +$61M |
| AGIO - Agios Pharmaceuticals | 1.23% | Add +0.1% | 5,660,866 | $44.43 | $252M | +6,364 | +$8M |
| MA - Mastercard · CL A | 1.22% | Add +9.5% | 506,671 | $493.80 | $250M | +43,900 | +$46M |
| SPGI - S&P Global | 1.20% | Reduce −39.2% | 475,334 | $516.62 | $246M | −306,600 | −$103M |
| SHW - Sherwin Williams | 1.04% | Reduce −14.1% | 555,950 | $381.67 | $212M | −91,600 | +$19M |
| V - VISA · CL A | 1.01% | Reduce −8.5% | 752,010 | $274.95 | $207M | −69,876 | −$9M |
| BEAM - Beam Therapeutics | 0.98% | Add +3.7% | 8,208,123 | $24.50 | $201M | +295,000 | +$16M |
| WWD - Woodward | 0.97% | New | 1,154,000 | $171.51 | $198M | +1,154,000 | +$198M |
| EDU — | 0.94% | Add +72.4% | 2,533,600 | $75.84 | $192M | +1,064,010 | +$78M |
| Stericycle | 0.94% | New | 3,146,000 | $61.00 | $192M | +3,146,000 | +$192M |
| YMM - Full Truck Alliance | 0.91% | Reduce −20.1% | 20,665,548 | $9.01 | $186M | −5,184,755 | −$22M |
| Southwestern Energy | 0.90% | New | 25,993,099 | $7.11 | $185M | +25,993,099 | +$185M |
| BHVN - Biohaven | 0.89% | Add +62.0% | 3,642,589 | $49.97 | $182M | +1,394,589 | +$104M |
| Masimo | 0.82% | Add +12.4% | 1,258,563 | $133.33 | $168M | +139,000 | +$27M |
| HWM - Howmet Aerospace | 0.74% | Reduce −40.4% | 1,514,339 | $100.25 | $152M | −1,027,500 | −$46M |
| Squarespace · CLASS A | 0.66% | New | 2,891,632 | $46.43 | $134M | +2,891,632 | +$134M |
| THC - Tenet Healthcare | 0.56% | Add +0.7% | 692,442 | $166.20 | $115M | +5,000 | +$24M |
| Holding | 0.51% | Add +7.2% | 3,150,857 | $33.33 | $105M | +210,357 | +$26M |
| BEKE - KE | 0.46% | Hold | 4,740,833 | $19.91 | $94M | — | — |
| ICLR - ICON | 0.31% | Add +23.9% | 220,800 | $287.31 | $63M | +42,600 | +$8M |
| CRNX — | 0.29% | Add +133.8% | 1,162,000 | $51.10 | $59M | +665,000 | +$37M |
| COR - Cencora | 0.26% | Reduce −3.1% | 235,200 | $225.08 | $53M | −7,600 | −$2M |
| GBTC - Ishares Bitcoin Trust ETF | 0.25% | New | 1,440,000 | $36.13 | $52M | +1,440,000 | +$52M |
| LBRDA - Liberty Broadband | 0.25% | New | 660,000 | $77.29 | $51M | +660,000 | +$51M |
| HR - Healthcare Rlty Tr · CL A | 0.23% | New | 2,603,000 | $18.15 | $47M | +2,603,000 | +$47M |
| CNC - Centene Del | 0.23% | Reduce −71.6% | 614,917 | $75.28 | $46M | −1,553,258 | −$97M |
| CNTA - Centessa Pharmaceuticals | 0.22% | Add +41.0% | 2,814,318 | $15.99 | $45M | +818,318 | +$27M |
| BBIO - Bridgebio Pharma | 0.22% | New | 1,747,000 | $25.46 | $44M | +1,747,000 | +$44M |
| LQDA - Liquidia | 0.16% | Add +60.1% | 3,290,956 | $10.00 | $33M | +1,235,956 | +$8M |
| GDS — | 0.15% | Add +24.9% | 1,531,133 | $20.40 | $31M | +305,000 | +$20M |
| SIMO - Silicon Motion Technology | 0.15% | Reduce −9.4% | 514,000 | $60.74 | $31M | −53,534 | −$15M |
| ENTA - Enanta Pharmaceuticals | 0.11% | Add +0.6% | 2,108,262 | $10.36 | $22M | +13,262 | −$5M |
| Savara | 0.09% | Hold | 4,560,000 | $4.24 | $19M | — | — |
| EVH - Evolent Health · CL A | 0.09% | New | 639,000 | $28.28 | $18M | +639,000 | +$18M |
| Zymeworks | 0.08% | Reduce −15.0% | 1,361,000 | $12.55 | $17M | −240,000 | +$3M |
| TAL - Tal Education Group | 0.08% | Hold | 1,365,000 | $11.84 | $16M | — | — |
| TECX - Tectonic Therapeutic | 0.08% | Add +20.7% | 520,397 | $30.30 | $16M | +89,387 | +$9M |
| PGNY - Progyny | 0.08% | Reduce −28.8% | 931,307 | $16.76 | $16M | −377,193 | −$22M |
| TWST - Twist Bioscience | 0.08% | Add +77.4% | 340,650 | $45.18 | $15M | +148,650 | +$6M |
| DYN - Dyne Therapeutics | 0.08% | Add +7033.3% | 428,000 | $35.92 | $15M | +422,000 | +$15M |
| NUVL - Nuvalent | 0.08% | New | 150,000 | $102.30 | $15M | +150,000 | +$15M |
| AMGN - Amgen | 0.07% | Reduce −79.7% | 47,000 | $322.21 | $15M | −185,000 | −$57M |
| VYGR - Voyager Therapeutics | 0.07% | Hold | 2,292,000 | $5.85 | $13M | — | — |
| FLUT - Flutter Entmt | 0.06% | Reduce −73.5% | 53,270 | $237.28 | $13M | −147,530 | −$24M |
| Biodesix | 0.04% | Add +146.9% | 4,636,791 | $1.78 | $8M | +2,758,616 | +$5M |
| Latam Airlines Group SA | 0.04% | New | 300,377 | $26.41 | $8M | +300,377 | +$8M |
| Ventyx Biosciences | 0.03% | Hold | 3,170,000 | $2.18 | $7M | — | — |
| TMDX - Transmedics Group | 0.03% | Add +2100.0% | 44,000 | $157.00 | $7M | +42,000 | +$7M |
| Helix Acquisition Ii · CL A | 0.03% | Hold | 600,000 | $10.45 | $6M | — | — |
| ANAB - Anaptysbio | 0.03% | New | 183,876 | $33.50 | $6M | +183,876 | +$6M |
| Metals Acquisition | 0.03% | Hold | 410,197 | $13.85 | $6M | — | — |
| CYTK - Cytokinetics | 0.03% | Hold | 102,400 | $52.80 | $5M | — | — |
| AMLX - Amylyx Pharmaceuticals | 0.02% | Hold | 1,150,221 | $3.24 | $4M | — | — |
| Swiftmerge Acquisition · CLASS A | 0.02% | Hold | 300,000 | $11.04 | $3M | — | — |
| PCVX - Vaxcyte | 0.02% | Reduce −90.3% | 28,000 | $114.27 | $3M | −262,000 | −$19M |
| PRME - Prime Medicine | 0.01% | Hold | 750,000 | $3.87 | $3M | — | — |
| VNET - VNET Group | 0.01% | Hold | 650,000 | $4.08 | $3M | — | — |
| ALVO - Alvotech | 0.01% | New | 199,675 | $11.90 | $2M | +199,675 | +$2M |
| Metagenomi | 0.01% | Reduce −21.3% | 1,057,201 | $2.17 | $2M | −286,000 | −$3M |
| BRKR - Bruker | 0.01% | New | 32,000 | $69.06 | $2M | +32,000 | +$2M |
| Elevation Oncology | 0.01% | Reduce −2.0% | 3,527,482 | $0.5999 | $2M | −70,936 | −$8M |
| SMC - Summit Midstream | 0.01% | New | 58,214 | $35.03 | $2M | +58,214 | +$2M |
| Marblegate Acquisition · CL A | 0.01% | Hold | 150,000 | $11.05 | $2M | — | — |
| MDGL - Madrigal Pharmaceuticals | 0.00% | Hold | 3,319 | $212.22 | $704K | — | — |
| Cara Therapeutics | 0.00% | Hold | 1,556,251 | $0.3080 | $479K | — | — |
| ROIV - Roivant Sciences | 0.00% | Reduce −94.5% | 37,000 | $11.54 | $427K | −636,000 | −$7M |
| HCA - Hca Healthcare | 0.00% | Hold | 1,000 | $406.43 | $406K | — | — |
| Blueprint Medicines | 0.00% | Hold | 4,000 | $92.50 | $370K | — | — |
| KRYS - Krystal Biotech | 0.00% | Hold | 2,000 | $182.03 | $364K | — | — |
| AXSM - Axsome Therapeutics | 0.00% | Hold | 4,000 | $89.87 | $359K | — | — |
| UTHR - United Therapeutics | 0.00% | Reduce −99.3% | 1,000 | $358.35 | $358K | −142,000 | −$45M |
| IMVT - Immunovant | 0.00% | Hold | 12,000 | $28.51 | $342K | — | — |
| GKOS - Glaukos | 0.00% | Hold | 2,600 | $130.28 | $339K | — | — |
| ACLXGBX - Arcellx | 0.00% | Hold | 4,000 | $83.51 | $334K | — | — |
| BTSG - Brightspring Health Svcs | 0.00% | Hold | 22,000 | $14.68 | $323K | — | — |
| Sage Therapeutics | 0.00% | Hold | 42,800 | $7.22 | $309K | — | — |
| MMSI - Merit Med Sys | 0.00% | Hold | 3,000 | $98.83 | $296K | — | — |
| EHC - Encompass Health | 0.00% | Hold | 3,000 | $96.64 | $290K | — | — |
| SBRA - Sabra Health Care Reit | 0.00% | Hold | 14,000 | $18.61 | $261K | — | — |
| GMED - Globus Med · CL A | 0.00% | Hold | 3,600 | $71.54 | $258K | — | — |
| GRFS - Grifols S A | 0.00% | Hold | 28,000 | $8.88 | $249K | — | — |
| IOVA - Iovance Biotherapeutics | 0.00% | Hold | 26,000 | $9.39 | $244K | — | — |
| ARQT - Arcutis Biotherapeutics | 0.00% | Hold | 26,000 | $9.30 | $242K | — | — |
| CHE - Chemed | 0.00% | Hold | 400 | $600.97 | $240K | — | — |
| HIMS - Hims & Hers Health · CL A | 0.00% | Add +30.0% | 13,000 | $18.42 | $239K | +3,000 | +$38K |
| OSCR - Oscar Health · CL A | 0.00% | Hold | 11,000 | $21.21 | $233K | — | — |
| RNAGBP - Avidity Biosciences | 0.00% | Hold | 5,000 | $45.93 | $230K | — | — |
| PACB — | 0.00% | Hold | 135,000 | $1.70 | $230K | — | — |
| HQY - Healthequity | 0.00% | Hold | 2,800 | $81.85 | $229K | — | — |
| R1 Rcm | 0.00% | Hold | 16,000 | $14.17 | $227K | — | — |
| RARE — | 0.00% | Reduce −96.0% | 4,000 | $55.55 | $222K | −95,000 | −$4M |
| INSM - Insmed | 0.00% | Reduce −99.5% | 3,000 | $73.00 | $219K | −565,000 | −$38M |
| NVAX - Novavax | 0.00% | Reduce −95.8% | 16,000 | $12.63 | $202K | −361,250 | −$5M |
| GERN - Geron | 0.00% | Reduce −99.7% | 43,000 | $4.54 | $195K | −16,794,000 | −$71M |
| SNDX - Syndax Pharmaceuticals | 0.00% | Hold | 10,000 | $19.25 | $193K | — | — |
| COGT - Cogent Biosciences | 0.00% | Reduce −96.0% | 17,000 | $10.80 | $184K | −408,161 | −$3M |
| AM6 - Amicus Therapeutics | 0.00% | Hold | 16,000 | $10.68 | $171K | — | — |
| ALT - Altimmune | 0.00% | Hold | 27,600 | $6.14 | $169K | — | — |
| CCCC - C4 Therapeutics | 0.00% | Hold | 28,000 | $5.70 | $160K | — | — |
| ARDX - Ardelyx | 0.00% | Hold | 23,000 | $6.89 | $158K | — | — |
| CGC - Canopy Growth | 0.00% | Hold | 30,000 | $4.82 | $145K | — | — |
| BYND - Beyond Meat | 0.00% | Hold | 19,000 | $6.78 | $129K | — | — |
| IRWD - Ironwood Pharmaceuticals · CL A | 0.00% | Hold | 13,000 | $4.12 | $54K | — | — |
| Lufax | 0.00% | Hold | 15,000 | $3.49 | $52K | — | — |
Showing top 50 of 128 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2024 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| AZNN — | 0.89% | Exit | 0 | $77.99 | $188M | −2,409,718 | −$188M |
| Holding | 0.23% | Exit | 0 | $40.89 | $49M | −1,190,000 | −$49M |
| CRSP - Crispr Therapeutics AG | 0.14% | Exit | 0 | $54.01 | $29M | −530,000 | −$29M |
| SYRE - Spyre Therapeutics | 0.07% | Exit | 0 | $23.51 | $16M | −666,000 | −$16M |
| PCG - Pg And E | 0.06% | Exit | 0 | $17.46 | $12M | −692,323 | −$12M |
| RIO - Rio Tinto | 0.04% | Exit | 0 | $65.93 | $9M | −137,500 | −$9M |
| Berenson Acquisition I · CL A | 0.01% | Exit | 0 | $10.65 | $3M | −285,715 | −$3M |
| Arya Sciences Acqu Iv · CL A | 0.01% | Exit | 0 | $11.46 | $2M | −200,000 | −$2M |
| NRIX - Nurix Therapeutics | 0.01% | Exit | 0 | $20.87 | $2M | −108,799 | −$2M |
| Summit Midstream Partners | 0.01% | Exit | 0 | $35.56 | $2M | −58,214 | −$2M |
| QTRX - Quanterix | — | Exit | 0 | $13.21 | $1M | −80,000 | −$1M |
| Forte Biosciences | — | Exit | 0 | $0.5369 | $972K | −1,810,455 | −$972K |
| VEEV - Veeva Sys · CL A | — | Exit | 0 | $183.05 | $663K | −3,622 | −$663K |
| Merus | — | Exit | 0 | $59.25 | $237K | −4,000 | −$237K |
| APLSUSD - Apellis Pharmaceuticals | — | Exit | 0 | $38.33 | $230K | −6,000 | −$230K |
| IONS - Ionis Pharmaceuticals | — | Exit | 0 | $47.71 | $229K | −4,800 | −$229K |
| HUM - Humana | — | Exit | 0 | $373.33 | $224K | −600 | −$224K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2